Evidence map›Paper›PMID 34117045›Full record

ArticleBMJ open2021

Warwick-India-Canada (WIC) global mental health group: rationale, design and protocol.

Swaran P Singh, Mohapradeep Mohan, Srividya N Iyer, Caroline Meyer, Graeme Currie, Jai Shah, Jason Madan, Max Birchwood, Mamta Sood, Padmavati Ramachandran and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Swaran P Singh *Division of Mental Health & Wellbeing, Warwick Medical School, University of Warwick, Coventry, UK s.p.singh@warwick.ac.uk.ORCID 0000-0003-3454-2089
Mohapradeep Mohan *Division of Mental Health & Wellbeing, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0003-1665-2081
Srividya N IyerPrevention and Early Intervention Program for Psychosis (PEPP-Montréal), Douglas Mental Health University Institute, Verdun, Quebec, Canada.
Caroline MeyerWMG and Warwick Medical School, University of Warwick, Coventry, UK.
Graeme CurrieWarwick Business School, University of Warwick, Coventry, UK.
Jai ShahPrevention and Early Intervention Program for Psychosis (PEPP-Montréal), Douglas Mental Health University Institute, Verdun, Quebec, Canada.
Jason MadanWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0003-4316-1480
Max BirchwoodDivision of Mental Health & Wellbeing, Warwick Medical School, University of Warwick, Coventry, UK.
Mamta SoodDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Padmavati RamachandranSchizophrenia Research Foundation, Chennai, Tamil Nadu, India.ORCID 0000-0002-0380-8617
Rakesh K ChaddaDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Richard J LilfordInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Thara RangaswamySchizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Vivek FurtadoDivision of Mental Health & Wellbeing, Warwick Medical School, University of Warwick, Coventry, UK.
WIC Consoritum
University of Warwick · GBAll India Institute of Medical Sciences · INDouglas Mental Health University Institute · CASchizophrenia Research Foundation · INUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe primary aim of the National Institute of Health Research-funded global health research group, Warwick-India-Canada (WIC), is to reduce the burden of psychotic disorders in India. India has a large pool of undetected and untreated patients with psychosis and a treatment gap exceeding 75%. Evidence-based packages of care have been piloted, but delivery of treatments still remains a challenge. Even when patients access treatment, there is minimal to no continuity of care. The overarching ambition of WIC programme is to improve patient outcomes through (1) developing culturally tailored clinical interventions, (2) early identification and timely treatment of individuals with mental illness and (3) improving access to care by exploiting the potential of digital technologies. METHODS AND ANALYSIS: This multicentre, multicomponent research programme, comprising five work packages and two cross-cutting themes, is being conducted at two sites in India: Schizophrenia Research Foundation, Chennai (South India) and All India Institute of Medical Sciences, New Delhi (North India). WIC will (1) develop and evaluate evidence-informed interventions for early and first-episode psychosis; (2) determine pathways of care for early psychosis; (3) investigate the efficacy and cost-effectiveness of community care models, including digital and mobile technologies; (4) develop strategies to reduce the burden of mental illnesses among youth; (5) assess the economic burden of psychosis on patients and their carers; and (6) determine the feasibility of an early intervention in psychosis programme in India. ETHICS AND DISSEMINATION: This study was approved by the University of Warwick's Biomedical and Scientific Research Ethics Committee (reference: REGO-2018-2208), Coventry, UK and research ethics committees of all participating organisations. Research findings will be disseminated through peer-reviewed scientific publications, presentations at learnt societies and visual media.

Indexed as

Mental HealthPsychotic DisordersAdolescentCanadaGlobal HealthHumansIndiaadult psychiatrychild & adolescent psychiatryschizophrenia & psychotic disorders

Identifiers

PMID34117045
PMCPMC8202113
OpenAlexW3172784824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.